#-supreme-cellcarta-badge-grid-48-464{badges-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/06/CAP_006_Icons_exploration_V1-13.png","image_alt":"","title":"In-Depth Analysis","description":"A sensitive,accurate,simple,and scalable workflow."},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/CAP_006_Icons_exploration_V1-03.png","image_alt":"","title":"Imaged Using mIF","description":"DAPI,CD45,EpCAM,and ≤2 select biomarkers assessed at once. "},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/CAP_006_Icons_exploration_V1-09.png","image_alt":"","title":"Seamless Hand-off","description":"Expert slide preparation,handling,and processing."},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/CAP_006_Icons_exploration_V1-06.png","image_alt":"","title":"Data Management","description":"A complete data management pipeline for high-dimensional images. "}]}#-supreme-cellcarta-differentiators-15-144{items-data:[{"text":"High-End Scientific Capabilities"},{"text":"Non-Invasive Collection "},{"text":"Global Execution "},{"text":"Cutting-Edge Platforms"},{"text":"Adaptable Workflows "}]}#-supreme-cellcarta-faq-13-144{items-data:[{"faq_question":"What are the advantages of liquid biopsies? ","faq_answer":"Liquid biopsy samples can be repeatedly extracted from patients in a simple,minimally invasive manner,making them ideal for long-term patient monitoring in a clinical program. From a single collection,dynamic information for cfDNA,RNA,exosomes,and CTC analysis can be determined,providing comprehensive insight into tumor evolution,patient management,and treatment response overtime."},{"faq_question":"What liquid biopsy platforms are offered? ","faq_answer":"<p>Your liquid biopsy samples can be used to extract valuable data across all our areas of expertise &ndash;proteomics,genomics,histopathology,and immune monitoring. Depending on your sample type and study endpoint,we can tailor which platforms are run,optimizing your data to align best with your study&rsquo;s specification. These platforms include <a href=\"../../../capabilities/genomics/digital-pcr-services/\" target=\"_self\">dPCR</a>,nCounter,<a href=\"../../../capabilities/genomics/sequencing-services/ngs/\" target=\"_self\">next-generation sequencing</a>,<a href=\"../../histopathology/\" target=\"_self\">histopathology</a>,<a href=\"../../immunoassay-services/\" target=\"_self\">immunoassays</a>,<a href=\"../../../platforms/flow-cytometry/\" target=\"_self\">flow cytometry</a>,and <a href=\"../../../platforms/mass-spectrometry/\" target=\"_self\">mass spectrometry</a>.</p>\n<p>CellCarta is a certified RareCyte provider,enabling robust CTC analysis services from your liquid biopsy samples through mIF-based platforms.</p>"},{"faq_question":"What are the advantages of using RareCyte? ","faq_answer":"<p>CellCarta is a RareCyte service provider,a robust workflow to simplify cfDNA and CTC analysis from liquid biopsy samples. RareCyte has several advantages,especially for large-scale clinical trials.</p>\n<p>Our slide preparation is density-based and eliminates manual wash steps,reducing the risk of cell loss and user error.</p>\n<p>Identified CTCs are immunophenotyped using automated IF assays (DAPI,CD45,EpCAM,CK),and up to two additional biomarkers can be assessed for in-depth phenotypic characterization. Our imaging team then uses the CyteFinder platform and integrated ML/AI image analysis software to classify CTCs with ease.</p>\n<p>The RareCyte workflow allows CTCs to be physically isolated from the slide for downstream multi-omics characterization.</p>"},{"faq_question":"What assays do you run for liquid biopsy samples? ","faq_answer":"<p>Our team of experts can run a variety of assays,including TSO500 for comprehensive NGS-based genomic profiling,oncoReveal Essential LBx and oncoReveal Fusion LBx for targeted liquid biopsy variant detection,nCounter,and Aspyre Lung for NSCLC biomarker analysis in blood samples.</p>\n<p>For mutation-specific testing,we offer cobas and Qiagen therascreen kits targeting clinically relevant genes including EGFR,KRAS,BRAF,PIK3CA,and FGFR.</p>\n<p>Where no off-the-shelf assay fits your endpoints,our scientists can develop and validate custom assays tailored to your study.</p>"},{"faq_question":"What are the advantages of using TSO500?","faq_answer":"<p>The TruSight Oncology 500 (TSO500) panel interrogates 523 cancer-related genes from DNA and 55 from RNA,enabling detection of SNVs,indels,CNVs,and gene fusions from both tissue and liquid biopsy (plasma) samples in a single,consolidated workflow.</p>\n<p>By combining multiple biomarker readouts into one NGS assay,TSO500 requires less sample material,shortens turnaround time,and aiding in the identification of actionable genomic alterations. Its automated workflow supports up to 192 samples per run,making it highly scalable for large clinical programs.</p>"}]}#-supreme-cellcarta-featured-resources-16-144{cards-data:[{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"},{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar-2.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"},{"image_url":"\/wp-content\/uploads\/2026\/05\/webinar-3.jpg","card_type":"Webinar","date":"Feb 12","reading_time":"Reading Time - 5 minutes","title":"Resources Title Goes Here","description":"Lorem ipsum dolor sit amet,consectetuer adipiscing elit. Aenean commodo ligula eget dolor.","url":"#"}]}#-supreme-cellcarta-service-blocks-45-176{blocks-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Genomics-Services-449.jpg","image_alt":"","title":"Genomics Services ","description":"Genomics solutions for all phases of drug development and CDx development. ","button_text":"Discover","button_url":"/capabilities/genomics/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Assays-by-Mutations-10-IMG_2181.jpg","image_alt":"","title":"Immunoassays ","description":"Measure the expression of analytes for biomarker discovery and immune monitoring. ","button_text":"Discover","button_url":"/capabilities/immunoassay-services/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-20-2-scaled.jpg","image_alt":"","title":"Mass Spectrometry","description":"Sensitive and accurate platform for scalable proteomic monitoring and bioanalysis under GCLP and QC conditions.","button_text":"Discover","button_url":"/platforms/mass-spectrometry/","button_target":"_self"}]}#-supreme-cellcarta-tab-content-11-144{tabs-data:[{"tab_title":"Tailored Workflow","content_title":"","content_body":"<p>Uncover key cellular insights using our various liquid biology platforms,including:</p>\n<ul>\n<li><a href=\"../digital-pcr-services/\" target=\"_self\">Digital PCR</a></li>\n<li><a href=\"../qpcr-services/\" target=\"_self\">Quantitative PCR</a></li>\n<li><a href=\"../sequencing-services/\" target=\"_self\">Sequencing services</a></li>\n<li><a href=\"../../immunoassay-services/\" target=\"_self\">Immunoassays</a></li>\n<li><a href=\"../../../platforms/mass-spectrometry/\" target=\"_self\">Mass spectrometry</a></li>\n<li><a href=\"../../../platforms/flow-cytometry/\" target=\"_self\">Flow cytometry</a></li>\n</ul>\n<p>Depending on your research context,sample type,and clinical endpoints,our team of experts can tailor which platforms are relevant to your study,ensuring quality data,not just quantity.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Tailored-Workflow-tab96-IMG_2627.jpg","image_alt":""},{"tab_title":"OTS & Custom Panels ","content_title":"","content_body":"<p>Our workflows can support key off-the-shelf (OTS) assays to uncover in-depth information regarding your samples,including:</p>\n<ul>\n<li>TruSight Oncology 500 (TSO500) ctDNA v2 (Illumina)</li>\n<li>OncoReveal (Pillar Biosciences)</li>\n<li>Aspyre&reg;Lung (Biofidelity)</li>\n</ul>\n<p>Customized panels can also be developed to support your sample type and targets of interest,with validation services in-place to meet your study at any stage. <a href=\"../../../contact/\" target=\"_self\">Contact our team to learn more</a>.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/OTS-Custom-Panels-tab-22.jpg","image_alt":""},{"tab_title":"Sample Logistics ","content_title":"","content_body":"<p>Receive access to our in-house biobank,a database that is fully searchable by phenotype,biomaterial type,and disease indicators.</p>\n<p>Our global network of laboratories provides high-quality <a href=\"../../../clinical-trial-services/sample-logistics/pbmc-processing/\" target=\"_self\">PBMC processing</a> and <a href=\"../../../clinical-trial-services/sample-logistics/sample-management/\" target=\"_self\">sample management</a> services to ensures proper handling,transport,and storage of samples while in our care,supporting data integrity and streamlining clinical trial progression.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Sample-Logistics-tab-408.jpg","image_alt":""}]}